Raytheon Secures $49.7 Million Navy Contract for Weapon System Repairs
The U.S. Navy has awarded Raytheon a $49.7 million delivery order to repair components for its Close-In Weapon System, with work expected to be completed by 2032.
Latest by Marcus Chen
Boeing Secures $43 Million DoD Contract for UAE C-17 Upgrades
The aerospace giant will install advanced missile defense systems on the United Arab Emirates' C-17 transport aircraft under a firm-fixed-price agreement funded through a Foreign Military Sale.
Interactive Brokers Q2 Profit Surges 35% on Robust Trading and Higher Interest Income
The brokerage firm reported a significant jump in second-quarter earnings, driven by a 36% increase in daily average revenue trades and a 23% rise in net interest income amid a strong rally in U.S. equity markets.
US Treasury Warns Wall Street Over 'Abusive' Tax Strategies
The U.S. Treasury Department is scrutinizing several popular tax-advantaged investment products, calling them potentially abusive and signaling a future crackdown, according to a Bloomberg News report.
S&P/BMV IPC Gains 0.88%, Led by Industrial and Consumer Stocks
Mexico's benchmark S&P/BMV IPC index advanced 0.88% on Tuesday, with gains in industrial and consumer-focused sectors offsetting broader market declines.
Nvidia's Vera Rubin Platform Shows 10x Power Efficiency Gain Over Blackwell, Enters Production
Nvidia announced its next-generation Vera Rubin AI platform is entering production, with partner CoreWeave reporting benchmark results showing a 10x improvement in throughput per megawatt over the current Blackwell architecture.
Seattle U.S. Attorney Sues Trump Administration Over Legality of Firing
Roger Rogoff, who was fired as the U.S. Attorney for Seattle just one hour after being appointed by judges, has filed a lawsuit challenging the president's authority to remove him. The case tests the legal boundaries for dismissing court-appointed prosecutors filling vacant positions.
Alaska Air Q3 Profit Forecast Trails Estimates Amid Elevated Fuel Costs
The carrier projects third-quarter earnings well below Wall Street expectations, citing the continued pressure of high jet fuel prices despite signs of resilient travel demand. Shares fell in after-hours trading following the announcement.
Celldex Shares Plunge After Prurigo Nodularis Drug Fails Phase 2 Trial
Celldex Therapeutics (CLDX) stock fell sharply in after-hours trading after its drug candidate, barzolvolimab, failed to meet its primary and secondary goals in a Phase 2 study for the skin condition prurigo nodularis.